Intro
Myofascial pelvic pain (MFPP) is distinguished by hypersensitive points in the muscle tissues around the pelvic floor that cause referred pain once triggered (i.e., stretching, unpleasant procedures, or emotional disturbances) [ 1 ]. Globally, the prevalence of MFPP in women with chronic pelvic pain is thought to range from 22% to 94%, and up to 85% of women with gynecologic, urologic, or colorectal pain issues also have MFPP [ 2 , 3 ]. Latent trigger points can be asymptomatic and cause discomfort. However, as the pain worsens, it frequently interferes with many aspects of daily life, causing painful spasms, dyspareunia, emotional disorders, and sleep disturbance, as well as having negative effects on social life, work capability, and leads to high demands on sick leave [ 1 , 4 ]. Patients of reproductive age (18–49 years old) are without a doubt the population that warrants significant attention due to their high prevalence of chronic pelvic pain [ 5 ]. Additionally, sexual pain or dyspareunia caused by MFPP makes their conception challenging. Moreover, patients are counseled against becoming pregnant until their pain relief or else run the danger of discomfort worsening as pregnancy progresses.
Pain intensity is the major determinant defining the impact of pain on the patient and the aim for therapy [ 4 ]. Furthermore, the fear-avoidance model (FAM) [ 6 ], a well-established biopsychosocial framework for clinical pain conditions, proposes that pain catastrophizing and fear of movement/(re)injury (i.e., kinesiophobia) are significant determinants of pain intensity and disability. The importance of self-efficacy in pain management has also been established in various kinds of chronic pain [ 7 ]. However, while it is generally recognized that there is a connection between pain intensity, the principal components of the FAM, self-efficacy and disruptions in daily life, the mechanisms that contribute to this relationship among reproductive-age patients with MFPP remain unclear.
The duration of pain and its interference following the onset of pelvic pain may be attributed to various causes, such as widespread pain, sensory incongruence, social disengagement, and a negative state of mind. The FAM, in particular, has been widely accepted to explain that it is not pain itself, but rather how pain is interpreted that is responsible for either speedy recovery or the progression of chronic pain. To begin with, it has been established that pain catastrophizing, a psychological condition characterized by an excessive focus on excruciating sensations and a feeling of helplessness while dealing with pain, is a significant and constant psychological predictor of reduced functioning [ 8 ]. For example, in 184 patients with chronic pelvic pain, Chen A et al. discovered a significant correlation between catastrophizing and severity and number of pain comorbidities [ 9 ]. Moreover, a review of 63 articles found evidence for an association between a greater degree of kinesiophobia and higher levels of pain severity and low quality of life [ 10 ]. MFPP, in particular, would be a consequence of central sensitization [ 11 ], which may interact with pain catastrophizing and kinesiophobia to trigger an exaggerated reaction towards pain, causing patients to compromise their function and, as a result, experience higher levels of daily interference [ 6 ].
While there is constant links between pain catastrophizing, kinesiophobia and worse outcomes, self-efficacy—that is, the belief in one’s capacity to carry out particular tasks—also plays a significant role in how one experiences and manages pain [ 12 ]. According to studies, individuals with similar pain levels typically experience less negative daily interference if they have a higher pain self-efficacy [ 7 , 13 ]. Furthermore, a meta-analysis of 27 articles found promising findings regarding the impact of self-efficacy in the prognosis of chronic musculoskeletal pain [ 13 ], self-efficacy seems to facilitate pain recovery and lessen the negative effects of pain on routine activities (e.g., reduced pain severity, decreased functional impairment, enhanced quality of life). It is commonly considered in the existing literature that self-efficacy usually acts as a mediator between pain and pain-related outcomes [ 13 ]. However, evidence also suggests that one’s sense of efficacy is an independent psychological capacity that may serve as a protective factor against the development of undesirable events caused by one’s condition, such as pain-related outcomes, illness sequela, and poor quality of life [ 14 ]. In this regard, we seek to investigate if, in reproductive-age patients with MFPP, self-efficacy alone or together with pain catastrophizing and kinetophobia forms a chain pathway that mediates pain and daily interference.
To the best of our knowledge, only two studies—neither of which focused on reproductive-age women or the pelvic region—have found a relationship between pain, psychological characteristics (e.g., pain catastrophizing and self-efficacy), and daily interference among patients with chronic myofascial pain [ 15 , 16 ]. According to Healy GM et al., patients with chronic myofascial pain who experienced a positive response to trigger point injection therapy had less anxiety before treatment and more self-efficacy in dealing with pain [ 15 ]. Similarly, Lumley MA et al. found that patients with chronic myofascial pain had less self-efficacy and more catastrophizing, which was moderately correlated with alexithymia and substantially correlated with affective pain and physical impairment [ 16 ]. This study is a cross-sectional study that sought to investigate the status of pain and its correlation with daily interference in childbearing-age women with MFPP through kinesiophobia, self-efficacy and pain catastrophizing, as well as to identify areas for future investigation and intervention based on the above findings. Pain intensity, daily interference, kinesiophobia (somatic focus and activity avoidance), self-efficacy, and pain catastrophizing (rumination, helplessness, and magnification) and their possible correlation were explored. Second, the potential involvement of pain catastrophizing and kinesiophobia in mediating the relationship between pain and daily interference was examined. Lastly, the possible independent or combined mediation role of self-efficacy in this population on the association between pain and the other outcomes of interest was investigated.
Results
A total of 202 verified childbearing-age respondents with MFPP were included in this analysis. The mean age of the participants was 35.76 ± 6.51 years (22–49), and BMI was 22.10 ± 3.08 kg/m 2 . As shown in Table 1 , most of the participants lived in urban (83.66%) and were married (89.11%); 106 participants (52.48%) had at least a college degree. 85 respondents (42.08%) had a monthly income less than CNY 5000, only 29 (14.36%) had not given birth, and 125 (61.88%) had a history of pelvic surgery. In addition, around half of the participants were currently diagnosed with gynecological disease (52.48%).
In this study, only 9 (4.46%) reported using over-the-counter medication for pain relief, and almost half (46.04%) had been treated for MFPP. 95 (47.03%) participants reported moderate pain, and 83 (41.09%) were categorized as “extreme catastrophizers”. Participants reported the most daily interference with mood (mean score of 4.96) and the least with walking (mean score of 3.72) ( Table 2 ).
The mean pain was 4.21 ± 1.77 (scores), the mean kinesiophobia was 31.11 ± 5.19 (scores), the mean pain-related self-efficacy was 35.52 ± 16.93 (scores), the mean pain catastrophizing was 25.50 ± 13.92 (scores), and the mean daily interference was 4.22 ± 2.54 (scores) ( Table 3 ). Based on the results of the Pearson correlations, participants perceived pain significantly correlated with kinesiophobia ( r = 0.332, P < 0.001), pain catastrophizing ( r = 0.432, P < 0.001) and daily interference ( r = 0.586, P 0.05). The participants who reported a high level of kinesiophobia indicated weaker beliefs in self-efficacy ( r = -0.539, P < 0.001) and more serious pain catastrophizing ( r = 0.694, P < 0.001) and daily interference ( r = 0.440, P <0.001). Pain-related self-efficacy correlated negatively with pain catastrophizing ( r = -0.488, P < 0.001) and daily interference ( r = -0.304, P < 0.001). The participants who reported a high level of pain catastrophizing indicated more serious daily interference ( r = 0.620, P < 0.001).
M mean, Min minimum, Max maximum, SD standard deviation
***Signifcant correlation, P value < 0.001
After removing the non-significant paths, the standardized fit indices indicated that the model was appropriate (see Fig 1 ): the CMIN/df was 1.995, GFI was 0.986, RMSEA was 0.070, TLI was 0.975, and the CFI was 0.986. For the factor loading of two subscales in TSK, “somatic focus” was 0.876 and “activity avoidance” was 0.752. For the factor loading of each subscale in PCS, helplessness was 0.945, magnification was 0.949, and rumination was 0.874.
Notes: *P<0.05; **P<0.01; ***P<0.001.
According to bivariate correlation analysis, there were eight factors significantly related to at least one main variables of the research, including age, BMI, location, occupation, monthly income, childbirth, currently diagnosed with gynecological disease, and previous pain treatment ( S1 Table ).
A mediation analysis was conducted using Model 6 in Hayes’ PROCESS to identify the possible serial mediating roles of kinesiophobia, self-efficacy, and pain catastrophizing in the association between pain and daily interference. First, we tested correlations between the variables in our proposed model and the potential covariates of age, BMI, location, occupation, monthly income, childbirth, currently diagnosed with gynecological disease, and previous pain treatment. As shown in Table 4 , the first control variable, age,was significantly related to kinesiophobia ( β = -0.112, P < 0.05) and self-efficacy ( β = 0.497, P < 0.01). Income was also significantly related to kinesiophobia ( β = -1.056, P < 0.001) and self-efficacy ( β = 2.533, P < 0.01). Currently diagnosed with gynecological disease was associated with higher pain catastrophizing ( β = 2.860, P < 0.05), and previous pain treatment was associated more serious daily interference ( β = 0.590, P < 0.05), so them were incorporated into the research model as controls.
Note: Only covariates that were significantly related to at least one variable of interest in the serial mediating model were included in the table.
*Signifcant correlation, P value < 0.05.
**Signifcant correlation, P value < 0.01.
***Signifcant correlation, P value < 0.001.
In support of our hypothesis, pain had a positive direct link to kinesiophobia ( β = 0.887, P < 0.001), pain catastrophizing ( β = 1.792, P < 0.001), and daily interference ( β = 0.571, P < 0.001). Kinesiophobia had a direct negative link to self-efficacy ( β = -1.652, P < 0.001), and a positive direct link to pain catastrophizing ( β = 1.310, P < 0.001). Lastly, as predicted, self-efficacy had a negative direct link to pain catastrophizing ( β = -0.171, P < 0.001), and pain catastrophizing positively affected daily interference ( β = 0.072, P < 0.001). However, there were no significant direct correlations between pain and self-efficacy, between kinesiophobia and daily interference, and between self-efficacy and daily interference (see Table 4 ).
Consistent with the hypothesis, our four-stage chain of mediation from pain to daily interference via higher kinesiophobia, lower self-efficacy, and higher pain catastrophizing in serial was significant ( P < 0.05). Kinesiophobia and pain catastrophizing significantly mediated the relations between pain and daily interference. Pain catastrophizing also direct mediated the relationship between pain and daily interference. The remaining paths were not significant (See Table 5 ). The mean indirect (unstandardized) effect was 0.013, the standard error was 0.006, and the 95% confidence interval for the mean indirect effect was [0.003, 0.027]. In addition, the variables in the final regression analysis accounted for nearly three-quarters ( R 2 = 0.728) of the variance in daily interference (see Table 4 and Fig 2 ).
Notes: ***P<0.001; Age, monthly income, currently diagnosed with gynecological disease, and previous pain treatment were entered into the model as control variables.
Note: Bootstrap samples for the bias-corrected interval is 5000; B regression coefficient; Std . Error , Standard error; 95% CI , 95% confidence Interval; ***Signifcant correlation, P value < 0.001.
Conclusions
According to the study findings, the association between pain and daily interference among reproductive-age women with MFPP can be explained in four ways. Pain influences the interference of daily activities, not only through its direct effects and the simple mediation of catastrophizing, but also through the sequential mediation of kinesiophobia and pain catastrophizing, and the four-stage serial mediation of kinesiophobia, self-efficacy and pain catastrophizing. For future clinical applications, kinesiophobia and self-efficacy, particularly pain catastrophizing, could be crucial psychological therapy targets for reproductive-age women with MFPP seeking to alleviate their pain perception and improve quality of life.
Materials|Methods
This was a hospital-based cross-sectional study conducted from 15 Nov 2022 to 10 Nov 2023. The Institutional Review Board of the primary hospital reviewed and approved this study on 02 Nov 2022 (No. I-22PJ633). Written informed consent was obtained before participants joined this study.
Childbearing-age women with clinically diagnosed MFPP (i.e., patients who self-reported moderate to severe pelvic pain that persisted for at least six months and recognition of pain trigger points on palpation assessment) attending partner hospitals to receive therapy were invited to participate in this study. A physician with more than ten years of experience in the management of pelvic floor dysfunction in women screened potential participants for eligibility. Inclusion criteria were female of reproductive age (18 to 49 years) who had ever had sex, non-menopause, and who had given informed consent. Pregnant women or participants with other pain-causing diseases (such as endometriosis, vaginal bleeding, and malignant tumors) were excluded from the study.
To guarantee the representativeness of the research findings, fourteen Grade A tertiary hospitals located in ten provinces of China (Liaoning in the Northeast, Beijing in the North, Henan and Hubei in the Central, Guangdong and Guangxi Zhuang Autonomous Region in the South, Qinghai in the Northwest, Yunnan in the Southwest, and Jiangsu and Shandong in the Eastern), which represent seven geographic and socioeconomic regions, were randomly selected as study regions.
During the research period, women aged 18–49 years with MFPP were consecutively recruited at the Department of Obstetrics and Gynecology or the Medical Rehabilitation Unit/Center of the fourteen partner hospitals. After ensuring patients understood the interview’s purpose, content and confidentiality, eligible patients were invited to participate in this study. Each participant self-reported a questionnaire on the online data management platform embedded in the WeChat application. The research team designed and verified the structured questionnaire, including demographic information, the Brief Pain Inventory, the Tampa Scale of Kinesiophobia, the Pain Self-Efficacy Questionnaire, and the Pain Catastrophizing Scale. For participants who were illiterate or had poor vision, the researchers verbally presented each item and option and verified that the questionnaires were filled out. As a result, all the data in this study is available.
Characteristic variables and the potential risk factors for daily interference are as follows: (1) general characteristics included birth year, height (cm), weight (kg), occupation, education, marital status, monthly income (CNY); (3) history of pelvic surgery (yes/no) and childbirth (yes/no); (3) disease status included constipation(yes/no) and “currently diagnosed with gynecological disease” (yes/no); (4) MFPP treatment-related variables included “whether used over-the-counter medication for pain relief” (yes/no) and “previous pain treatment” (yes/no). In addition, body mass index (BMI) was calculated from height and weight, which were divided into four classes by tertile: <24.0 kg/m 2 (underweight), 18.5–23.9 kg/m 2 (normal), 24.0–27.9 kg/m 2 (overweight), and ≥28.0 kg/m 2 (obese).
The Brief pain inventory (BPI) is used to assess the pain severity over the last 24 hours and the impact of pain on daily interference [ 17 ]. The domain of pain severity assess pain at its “worst”, “least”, “average”, and “current status”, which is rated on an 11-point scale from 0 (no pain) to 10 (unbearable pain). The daily interference domain of BPI assesses how much pain has bothered physical and affective activities (i.e., general activity, walking, work, mood, enjoyment of life, relations with others, and sleep), which is also rated on an 11-point scale from 0 (not at all) to 10 (completely interferes) and then summed for a mean score. Both domains are recommended to be measured in all chronic pain research, and Cronbach’s alpha for the 4 and 7 items was 0.862 and 0.951, respectively.
Kinesiophobia, the level of fear about movement causing pain and injury was assessed using the 11-item version of the Tampa Scale of Kinesiophobia (TSK-11) [ 18 ]. Each scored item is rated on a 4-point scale ranging from 1 “strongly disagree” to 4 “strongly agree” (score range 11–44), and higher total scores indicate elevated levels of physical activity-related fear. The TSK-11 consisting of two subscales—“Somatic Focus” (TSK-SF; belief in underlying and serious medical problems) and “Activity Avoidance” (TSK-AA; belief that activity may result in (re)injury or increased pain), which has been shown to have good reliability and validity (Cronbach’s alpha for the TSK, TSK-SF, and TSK-AA in this study was 0.913, 0.866, and 0.888, respectively) [ 18 ].
Pain-related self-efficacy, one’s confidence in performing a behavior despite experiencing pain, was assessed using the Pain Self-Efficacy Questionnaire (PSEQ) [ 19 ]. The PSEQ consists of 10 questions, with each item rated on a 7-point scale from 0 (not at all confident) to 6 (completely sure). The PSEQ has demonstrated good psychometric properties in individuals with pain, and Cronbach’s alpha in the current study was 0.964.
Pain catastrophizing, the exaggerated or negative thoughts related to actual or anticipated pain (pain catastrophizing), was evaluated using the Pain Catastrophizing Scale (PCS) [ 20 ]. The PCS is a 13-item scale with three subscales: “Helplessness” (PCS-H; sense of helplessness to alleviate pain), “Magnification” (PCS-M; worries that something serious may happen), and “Rumination” (PCS-R; continually dwelling on the pain). Each scored item is rated on a scale of 0 (not at all) to 4 (all of the time), with higher scores indicating worse. A total PCS score of 30 is defined as “extreme catastrophizing”, which means positive for pain catastrophization. This scale has been validated for people with chronic pain, and Cronbach’s alpha for the PCS, PCS-H, PCS-M, and PCS-R in the present study was 0.963, 0.933, 0.857, and 0.914, respectively.
Given the high consistency within each scale used in this study, the Item Parceling Strategy was employed, representing the dimension estimation with the mean value of items in each scale [ 21 ]. Since there were only eight variables in the final model: TSK-AA, TSK-SF, self-efficacy, PCS-rumination, PCS-magnification, PCS-helplessness, pain intensity, and daily interference, the minimum sample size for this study was 8 × 10 = 80, based on requirements of at least ten samples per variable. Furthermore, the recommended sample size for Structural Equation Modeling (SEM) is 200 [ 22 ], and this study ultimately enrolled 202 participants. Statistical analysis was conducted in SPSS 28.0, and two-sided with P < 0.05 was considered statistically significant.
Descriptive analysis and Pearson correlation were performed to examine the participants’ characteristics and variable associations. Means ( SD ), medians ( IQR ), or frequencies (percentage) were presented for the corresponding distribution of data. Linear regression was used to examine the factors associated with at least one favorable outcomes of the research (i.e., pain intensity, kinesiophobia, self-efficacy, pain catastrophizing, and daily interference) in reproductive-age women with MFPP, with the significant variables ( P < 0.05) from the univariate analysis tested in the proposed mediating model. Only covariate that were significantly related to at least one variable of interest were included in the final serial mediating model.
Given the adequate sample size and approximately normal distributed data, AMOS 23.0 using a full information maximum likelihood estimator was employed to investigate the association between pain and daily interference and whether this is serial mediated by kinesiophobia, self-efficacy, and pain catastrophizing. The final estimated model was established using a goodness-of-fit criterion between the sample data and the hypothesis framework. The following indicators were used to assess the fitness: (1) Chi-square value to degrees of freedom (CMIN/df); (2) goodness of fit index (GFI); (3) root mean squared error of approximation (RMSEA); (4) Tucker-Lewis Index (TLI); (5) Comparative Fit Index (CFI). The CMIN/df with a value between 1 and 3, GFI, TLI, and CFI with a value over 0.9, and RMSEA with a value below 0.8 indicate a good fit.
Hayes’ PROCESS macro program (Model 6) based on OLS regression was used for testing the proposed serial mediation model. The mean value across items was used to present the estimations, the 95% bias-corrected confidence intervals ( CIs ) using 5000 bootstrapped samples, and adjustments were made iteratively to background characteristics such as age, BMI, monthly income, and reproductive history. If the 95% CI does not include zero, then the direct and indirect effects are considered significant according to the above guidelines [ 23 ].
Supplementary Material
(DOCX)
(XLSX)
(DOCX)
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.